Gly-low: Clinical Trials

2 trials of Gly-low, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 withdrawn. 1 Early Phase 1, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Completed 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Gly-low: new trials by email Literature Review of Gly-low trials Research Report on Gly-low

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Methylglyoxal (MGO) Lowering Cocktail to Reduce Appetite in Obese Individuals
Gly-low, Placebo - Obesity, Aging
Phase 1 / Phase 2WithdrawnUniversity of California, San Francisco2024-12-012025-08-29
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
GLY-LOW - Insulin Resistance, Obesity
Early Phase 1CompletedHoskinson Health and Wellness Clinic132023-07-272025-06-10

Conditions studied

Obesity (2)  ·  Cardiovascular Diseases (1)  ·  Cognitive Dysfunction (1)  ·  Depression (1)  ·  Hyperlipidemias (1)  ·  Hyperphagia (1)  ·  Hypertension (1)  ·  Inflammation (1)  ·  Insulin Resistance (1)  ·  Sedentary Behavior (1)

Sponsors

Hoskinson Health and Wellness Clinic (1)  ·  University of California, San Francisco (1)

Countries

United States (2)

Top investigators

Marshall Stoller, MD (1)  ·  Sanjay Dhar, PhD (1)